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Abstract
Fe deficiency in early childhood is associated with long-term consequences for cognitive, motor and behavioural development; however
explorations in healthy children from low risk, high-resource settings have been limited. We aimed to explore associations between Fe status
and neurodevelopmental outcomes in low risk, healthy 2-year-olds. This study was a secondary analysis of a nested case–control subgroup
from the prospective, maternal-infant Cork Babies after Screening for Pregnancy Endpoints: Evaluating the Longitudinal Impact using
Neurological and Nutritional Endpoints (BASELINE) Birth Cohort Study. At 2 years, serum ferritin, Hb and mean corpuscular volume (MCV)
were measured and neurodevelopment was assessed using the Bayley Scales of Infant and Toddler Development (n 87). Five children had Fe
deficiency (ferritin <12 µg/l) and no child had Fe deficiency anaemia (Hb<110 g/l + ferritin<12 µg/l). Children with microcytosis (MCV<74 fl,
n 13) had significantly lower mean cognitive composite scores (88·5 (SD 13·3) v. 97·0 (SD 7·8), P= 0·04, Cohen’s d effect size= 0·8) than those
without microcytosis. The ferritin concentration which best predicted microcytosis was calculated as 18·4 µg/l (AUC= 0·87 (95% CI
0·75, 0·98), P<0·0001, sensitivity 92%, specificity 75%). Using 18·5 µg/l as a threshold, children with concentrations <18·5 µg/l had
significantly lower mean cognitive composite scores (92·3 (SD 10·5) v. 97·8 (SD 8·1), P= 0·012, Cohen’s d effect size= 0·6) compared with those
with ferritin ≥18·5 µg/l. All associations were robust after adjustment for potential confounding factors. Despite a low prevalence of Fe
deficiency using current diagnostic criteria in this healthy cohort, microcytosis was associated with lower cognitive outcomes at 2 years. This
exploratory study emphasises the need for re-evaluation of the diagnostic criteria for Fe deficiency in young children, with further research in
adequately powered studies warranted.
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Infants and young children are at particular risk of Fe defi-
ciency, which can lead to microcytosis and anaemia. Term
infants are born with Fe reserves that last for about 6 months;
however after this the infant relies on dietary intakes(1). In
addition to inadequate dietary Fe intakes, other dietary practices
including an increased consumption of unmodified cows’ milk
and reduced consumption of Fe-fortified products can also
result in Fe deficiency in infancy and early childhood(2,3).
Globally, it is estimated that 25% of preschool-age children
have Fe deficiency anaemia(4), while in Europe, the prevalence
of Fe deficiency ranges from 3 to 48%, with the majority of Fe
deficiency anaemia rates reported as below 5%(5). However,
the lack of consensus and therefore, the wide variability in
diagnostic criteria, including both biomarkers and thresholds
used for Fe deficiency and Fe deficiency anaemia in infants and
young children has challenged the interpretation of Fe status
worldwide.
Fe is essential for a number of processes in the developing
brain; altered neurotransmitter functioning, brain morphology
and reduced myelination have all been observed in Fe deficient
rodent models(6,7). Studies in humans have consistently
reported that Fe deficiency with and without anaemia in infancy
Abbreviations: BASELINE, Babies after Screening for Pregnancy Endpoints: Evaluating the Longitudinal Impact using Neurological and Nutritional Endpoints;
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and early childhood is associated with poorer cognitive, motor
and behavioural outcomes(8,9), with long-lasting effects into
adulthood(10).
Most studies exploring associations between Fe and neuro-
development have focused on 6–24-month-olds in low-
resource settings or in low socioeconomic subgroups; few
have explored associations in healthy young children in low
risk, high-resource settings. Therefore, the aim of this study was
to explore associations between Fe status, haematological
indices and neurodevelopmental outcomes at 2 years in an
apparently healthy, low risk population recruited through a
prospective birth cohort in Ireland.
Methods
Study design and participants
This study is a secondary analysis of a nested case–control
subgroup of participants that were recruited as part of the Cork
Babies after Screening for Pregnancy Endpoints (SCOPE):
Evaluating the Longitudinal Impact using Neurological and
Nutritional Endpoints (BASELINE) Birth Cohort Study between
March 2008 and January 2011. The BASELINE Study was
established as a follow-on to the SCOPE Ireland pregnancy
cohort study where 1768 low risk, nulliparous women were
recruited before 15 weeks’ gestation from Cork University
Maternity Hospital, as part of an international, multicentre
study aimed at investigating early indicators of pregnancy
complications(11). At 15 weeks’ gestation, research midwives
collected information on maternal socioeconomic status, occu-
pation, education, relationship status and a complete medical
history. Information on nutritional supplement use, recreational
activity, cigarette and alcohol use were recorded for the
3-month period before conception and during the first trimester.
Maternal anthropometric and clinical measurements were also
collected.
Women in the SCOPE Ireland study provided written
informed consent to the BASELINE Study for their infants at
15 weeks’ gestation (n 1537). Infants were followed pro-
spectively from birth, with assessments at day 2 and at 2, 6, 12
and 24 months. Assessments at 5 years of age were completed
in December 2016. Detailed information on early life environ-
ment, diet, lifestyle, health, growth and development was
gathered by interviewer-led questionnaires and clinical assess-
ments performed by trained researchers in accordance with the
Declaration of Helsinki, with further information on study
design and procedures reported previously(12). Ethical approval
was granted by the Clinical Research Ethics Committee of the
Cork teaching hospitals (ECM 5(9) 01/07/2008) and the study is
registered with the US Institutes of Health Clinical Trials Registry
(www.clinicaltrials.gov NCT01498965).
Developmental assessment
Within the BASELINE Study cohort, a nested case–control
subgroup (n 460) of firstborn children was selected at birth
for developmental assessment to examine the effect of fetal
growth on developmental outcomes(13). A statistician identified
the subgroup using the following criteria to select cases:
(1) children born small-for-gestational age, defined as a
customised birth weight centile (adjusted for maternal height,
booking weight, ethnicity, infant sex and gestational age(14))
less than the 10th centile (n 80) and (2) children with a body fat
percentage (measured by air-displacement plethysmography)
at 2 d less than the 10th centile for gestation and sex (n 81). The
control group consisted of appropriate-for-gestational age
(AGA) infants comprised of a stratified random sample taken
from across the customised birth weight centiles above the 10th
centile (n 299).
Participants identified as eligible for the nested subgroup at
birth were approached at their 24-month assessment to partake
in a detailed developmental assessment. The Bayley Scales of
Infant and Toddler Development, 3rd edition (BSID-III)(15) was
administered by a research psychologist trained in administra-
tion and scoring of the BSID-III who was blinded to the status of
the participants. The assessment consists of five scales: cogni-
tion, receptive communication, expressive communication, fine
motor and gross motor, with receptive and expressive com-
munication combined to form a language composite score and
fine and gross motor combined to form a motor composite
score. Published normative scores for the composite scales of
the BSID-Ш are a mean of 100 with a SD of 15; developmental
delay was defined as a score <85.
For the secondary, cross sectional analysis of the nested case–
control subgroup in this study, we only included the healthy,
AGA children from the control group to ensure exclusion of
those with fetal growth restriction, due to its confounding impact
on both Fe status and neurodevelopment(16,17). We also exclu-
ded children with acute infections, chronic disease/illness or
born premature (<37 weeks’ gestation).
Biological samples
Venous blood was collected from participants at the 24-month
assessment, in only those with parental consent. Whole blood
was sent to the Haematology Laboratory of Cork University
Hospital for determination of Hb and mean corpuscular volume
(MCV) on the Sysmex XE 2100 Automated Hematology System
(Sysmex America Inc.). Serum ferritin and high sensitivity
C-reactive protein (CRP) were analysed in the laboratory of the
Cork Centre for Vitamin D and Nutrition Research, University
College Cork, by immunoturbidimetric assay on the RX Monaco
Clinical Chemistry Analyser (Randox Laboratories Ltd, Co.).
Children with potential infections/inflammation as indicated by
an elevated CRP (>5mg/l) were excluded from analyses.
Statistical analysis
Data were analysed using IBM SPSS® for Windows™ version 21
(IBM Corp.). The distribution of data was examined by Q–Q
plots and histograms and descriptive statistics were generated;
medians and interquartile ranges (IQR) were used for not nor-
mally distributed data, whereas means and standard deviations
were provided for the BSID-III scores due to their normal dis-
tribution. Significant differences between groups in categorical
variables were evaluated using χ2 tests and independent t tests
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or Mann–Whitney U test for continuous variables. Effect sizes
were calculated using Cohen’s d effect size calculation. Given
the low numbers with Fe deficiency or Fe deficiency anaemia,
associations with individual haematological indices, first as
continuous variables and then as categorical variables (assigned
using commonly used thresholds) were explored. Univariate
and multivariate adjusted linear regression models were
developed to estimate the effect of each haematological index
on BSID-III scores. Factors explored in the univariate analysis
included maternal age, education, occupation, income, rela-
tionship status, Fe status, smoking status, BMI, mode of delivery
and infant sex, gestational age, birth anthropometric measures
and early feeding methods. Potential confounding factors that
were retained in the final multivariate models were identified if
they were significant at the 10% (P<0·1) level in the univariate
analysis. The residuals of the final model were normally dis-
tributed and were also assessed for linearity, homoscedasticity,
independence and for the presence of any outliers; associations
were expressed as adjusted estimates and 95% CI.
In addition, receiver operating characteristic curve analysis
was used to estimate the ferritin concentration cut-point to best
predict a MCV <74fl. The AUC, sensitivity and specificity were
calculated and the best possible cut-point for ferritin con-
centrations was defined at the highest Youden Index
((sensitivity + specificity) − 1).
Results
From the 460 children selected in the nested case–control
subgroup, 366 had a complete BSID-Ш assessment at 2 years
(forty-two had an incomplete assessment and fifty-two were
unable to attend the assessment). Only the children born AGA
(control group) were included in this secondary analysis
(n 240). The measurement of haematological indices at 2 years
was a prerequisite for this study, therefore children with no
blood sample provided at 2 years (n 144) were excluded. Those
with infection/inflammation at 2 years (n 3) or born premature
(n 6) were also excluded to provide a final sample size of
eighty-seven children (see Fig. 1). The principal characteristics
of those included in this study and their comparisons to the rest
of the study cohort that attended the 24-month assessment are
presented in Table 1.
Median Hb, MCV and serum ferritin concentrations at 2 years
of those included in this study are outlined in Table 1. Using
WHO definitions, Fe deficiency (serum ferritin<12 µg/l) was
observed in 6% (n 5) and no child had Fe deficiency anaemia
(serum ferritin<12 µg/l +Hb<110 g/l). Five children were
anaemic (Hb<110 g/l) and 15% (n 13) had a MCV <74fl, a
threshold indicative of microcytosis(3,18,19).
The median age of completion for the BSID-Ш assessment was
27·2 (IQR 26·0, 28·6) months. The distribution of subscale and
460 selected for nested
case–control subgroup  
366 with complete
BSID-III at 2 years 
52 unable to attend assessment
42 incomplete assessments 
87 children included in
final analysis 
Excluded:
6 born premature 
144 no blood sample
3 infection/inflammation
240 children born AGA
with complete BSID-III
at 2 years 
126 children born SGA or
BF % <10th centile (cases)
excluded 
Fig. 1. Flow diagram of study participants. BSID-III, Bayley Scales of Infant and Toddler Development (3rd edition); SGA, small-for-gestational age; AGA, appropriate-
for-gestational age; BF, body fat.
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composite scores of the BSID-Ш are presented in Table 2. There
was a low prevalence of scores indicative of developmental delay;
6% (n 5), 6% (n 5) and 3% (n 2) had scores <85 in the cognition,
language and motor composite scales, respectively.
Hb concentrations at 2 years were not associated with
BSID-Ш subscale or composite scores at 2 years. From the
univariate regression analysis, MCV was positively associated
with BSID-Ш cognitive composite (estimate 0·71; 95% CI 0·03,
1·40), P= 0·041) scores, however, this association was no
longer significant in the final model adjusted for potential
confounding factors (sex, birth weight, maternal education,
occupation, household income). Children with microcytosis
(MCV<74fl) had significantly lower BSID-Ш cognitive com-
posite scores than those without microcytosis (MCV≥74 fl),
with a strong Cohen’s d effect size of 0·8 (Table 3). This
association remained robust after adjustment for potential
confounding factors (adjusted estimate −6·7; 95% CI −12·9,
−0·5, P= 0·034, see online Supplementary Table S1 for full
multivariate model). There were no other significant differences
in study characteristics between those with and without
microcytosis at 2 years.
Of the five participants with cognitive delay (scores <85), four
had microcytosis. Only four children with microcytosis at 2 years
had concurrent Fe deficiency, indicated by ferritin concentrations
<12 µg/l. When the four children were excluded, those with
microcytosis and ferritin concentrations ≥12 µg/l (n 9) continued
to have lower mean cognitive composite (87·2 (SD 15·2) v. 96·9
(SD 7·7), P= 0·069) scores at 2 years, although this association
was weaker.
Serum ferritin concentrations were positively associated
with BSID-Ш fine motor subscale scores (estimate 0·04; 95% CI
0·01, 0·08, P= 0·036) at 2 years, which was robust after adjust-
ment for sex, birth weight, maternal education, occupation and
household income (adjusted estimate 0·04; 95% CI 0·01, 0·08,
Table 1. Principal characteristics of eligible participants with a blood sample and complete developmental assessment at
2 years (n 87) in comparison to the rest of the participants (n 1051) of the Cork Babies after Screening for Pregnancy Endpoints:
Evaluating the Longitudinal Impact using Neurological and Nutritional Endpoints (BASELINE) Birth Cohort Study*
(Numbers and percentages; medians and interquartile ranges (IQR))
Eligible (n 87) Not eligible (n 1051)
n % n % P†
Maternal characteristics
Age (at delivery, years) 0·086
Median 31·0 31·0
IQR 28·0, 33·0 29·0, 34·0
Caucasian 86 99 1032 99 0·999
Education 0·369
≤12 years 12 14 106 10
>12 years 75 86 942 90
Marital status 0·942
Single 5 6 52 5
Married/de facto 82 94 999 95
Household income 0·254
<€21000 8 9 53 5
€21 000–€63 000 38 44 402 40
€64 000–€105 000 33 38 414 41
>€105000 8 9 140 14
Professional employment 57 66 683 65 0·999
Infant characteristics
Male 44 51 542 51 0·947
Gestational age (weeks) 0·036
Median 40·6 40·3
IQR 39·6, 41·3 39·3, 41·0
Birth weight (kg) 0·010
Median 3·6 3·5
IQR 3·4, 3·8 3·2, 3·8
Birth length (cm) 0·022
Median 50·8 50·3
IQR 49·8, 52·0 49·0, 51·8
24-month assessment: Hb (g/l)‡ 0·374
Median 119·5 120·0
IQR 114·3, 124·0 116·0, 125·0
24-month assessment: mean corpuscular volume (fl)‡ 0·557
Median 77·1 76·2
IQR 74·4, 78·9 74·2, 78·5
24-month assessment: serum ferritin (μg/l)‡ 0·552
Median 20·9 20·0
IQR 15·3, 28·2 15·5, 27·3
* Maternal data collected at 15 weeks’ gestation unless otherwise stated.
† P values are comparisons between groups with χ2 or Mann–Whitney U tests.
‡ Haematological indices not available in all participants that were not eligible for this study.
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P=0·037). There were no significant associations between
Fe deficiency or Fe deficiency anaemia and BSID-Ш scores
at 2 years.
There was a strong positive association between MCV and
ferritin concentrations at 2 years (Spearman’s r 0·52, P<0·0001).
Children with microcytosis had significantly lower median fer-
ritin concentrations compared with those without microcytosis
(13·8 (IQR 11·6, 15·8) v. 21·1 (IQR 18·1, 39·3) µg/l, P<0·0001).
Following this observation, receiver operating characteristic
curve analysis was performed to estimate the ferritin con-
centration to best predict microcytosis in this subgroup of
healthy children. The ferritin concentration which best pre-
dicted microcytosis was calculated to be 18·4 µg/l (AUC= 0·87
(95 % CI 0·75, 0·98), P<0·0001, sensitivity 92%, specificity
75%). From this, a threshold of <18·5 µg/l was subsequently
used to investigate associations with BSID-Ш scores. Children
with ferritin concentrations <18·5 µg/l (n 28) had significantly
lower mean BSID-Ш cognitive composite (92·3 (SD 10·5) v. 97·8
(SD 8·1), P= 0·012, Cohen’s d effect size= 0·6) scores than
those with concentrations ≥18·5 µg/l. After adjustment for
confounding factors, ferritin concentrations <18·5 µg/l remained
inversely associated with cognitive composite (adjusted
estimate −6·0 (95% CI −10·2, −1·8), P= 0·006) scores at 2 years.
Discussion
This secondary analysis of a nested case–control subgroup of
children from a low risk maternal-infant birth cohort has
provided a much-needed exploration of associations between
haematological indices and neurodevelopmental outcomes in a
high-resource setting. In this apparently healthy cohort,
microcytosis, indicated by a MCV <74 fl was associated with
lower cognitive outcomes in 2-year-old children. We also
observed lower cognitive scores in children with ferritin
concentrations <18·5 µg/l, a threshold we estimated to predict
microcytosis in this group of children, highlighting an
association between currently defined normal or borderline low
ferritin concentrations, as opposed to overt Fe deficiency,
and adverse developmental outcomes in children in a high-
resource setting.
Neither Fe deficiency nor Fe deficiency anaemia was asso-
ciated with BSID-Ш scores at 2 years in this study, in contrast to
findings from earlier studies in more deprived populations(9,20).
However, our study was not adequately powered to accurately
explore these associations given the low prevalence of Fe
deficiency and Fe deficiency anaemia in our healthy cohort,
which we previously attributed to a dietary pattern of increased
Fe-fortified product consumption and low intakes of unmodi-
fied cows’ milk(2). Our rates of Fe deficiency and Fe deficiency
anaemia are much lower than contemporary data reported in
many other European countries(5) and the USA(21) and are in
particular contrast to the last report in Ireland from the 1990’s,
where 9% of 2-year-olds had Fe deficiency anaemia(22). In
addition, the cohort assessed in the current study differs from
most observational studies in that the majority of previous
studies have examined cohorts based in either low-resource
settings or in subgroups of low socioeconomic status(20,23).
Only two studies in Iceland(24,25) and an earlier study from the
UK(26) have investigated associations in young children in high-
resource settings similar to the current study. In low-resource
settings, the presence of confounding factors which may also
impact neurodevelopment including nutritional deprivation and
malnourishment can make it difficult to identify Fe deficiency as
the sole cause of neurodevelopmental alterations in such
populations.
Interestingly, microcytosis indicated by a low MCV at 2 years
was associated with significantly lower BSID-Ш cognitive
scores, even following adjustment for socioeconomic factors.
Linear associations between MCV and behaviour and language/
expression have been observed previously(24,27,28), however, to
our knowledge, this is the first study to show an adverse effect
of microcytosis on cognition. Microcytosis is characterised
by erythrocytes that are smaller than normal. In healthy
populations, this presentation is often due to a decreased
availability and supply of Fe resulting in a decreased production
of Hb, although other causes of microcytosis include anaemia of
chronic disease, congenital thalassaemias and sideroblastic
Table 3. Differences in Bayley Scales of Infant and Toddler Development
(3rd edition) subscale and composite scores between those with micro-
cytosis (mean corpuscular volume (MCV)<74 fl) and without microcytosis
(MCV≥74 fl) at 2 years





Mean SD Mean SD P * P †
Subscale scores
Cognition 7·7 2·7 9·4 1·6 0·044 0·036‡
Receptive
communication
9·1 3·6 10·8 2·4 0·076 0·373
Expressive
communication
10·7 4·6 11·3 2·9 0·615 0·721
Fine motor 10·2 2·6 11·7 2·4 0·059 0·121
Gross motor 9·3 1·6 9·7 2·4 0·647 0·665
Composite scores
Cognition 88·5 13·3 97·0 7·8 0·044 0·036‡
Language 99·9 23·4 106·2 14·4 0·291 0·390
Motor 98·6 11·6 104·5 10·9 0·108 0·173
* P values are comparisons between groups using independent t tests.
† P values from linear regression models adjusted for sex, birth weight, maternal
education, occupation and household income.
‡ Cohen’s d effect size=0·8
Table 2. Distribution of Bayley Scales of Infant and Toddler Development
(3rd edition) scores in study participants (n 87)
(Mean values and standard deviations; medians and interquartile ranges
(IQR))
Mean SD Median IQR
Subscale scores
Cognition 9·1 1·8 9·0 8·0, 10·0
Receptive communication 10·7 2·6 11·0 9·0, 13·0
Expressive communication 11·1 3·2 12·0 9.0, 13·0
Fine motor 11·5 2·6 11·0 10·0, 13·0
Gross motor 9·7 2·1 10·0 8·0, 11·0
Composite scores
Cognition 95·5 9·2 95·0 90·0, 100·0
Language 105·7 15·6 109·0 96·3, 115·0
Motor 103·8 11·4 103·0 97·0, 112·0
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anaemias(29). However, the microcytosis observed in this study
is almost certainly Fe deficiency related. Our cohort was
a healthy birth cohort population, with normal CRP levels
making chronic inflammation or disease unlikely. Our ethnic
diversity is low, 99% of our cohort were white Caucasian, with
no children of African or Mediterranean decent, making tha-
lassaemia an unlikely cause. Although we cannot fully rule out
lead poisoning as a cause of acquired sideroblastic anaemia, no
sideroblasts were reported on the manual blood films which
accompanied our full blood count analysis.
The finding that microcytosis was associated with reduced
cognitive outcomes in this low risk population is an important
one. It suggests that a low MCV may be a more specific marker
of functional Fe deficiency than very low serum ferritin con-
centrations, which are susceptible to much variation(30). Over
two-thirds of those with microcytosis presented with normal
serum ferritin concentrations (≥12 µg/l), therefore the use of
ferritin alone as a diagnostic tool would have resulted in a
number of children at risk of poorer cognitive outcomes being
undetected. Furthermore, despite the small numbers with cog-
nitive delay in this cohort, it is striking to note that the majority
of those with delay had microcytosis. This finding emphasises
the need for further consideration of the diagnostic criteria for
Fe deficiency in young children, with a need to assess Fe status
using multiple haematological indices to ensure no children at
risk of physiological or developmental consequences are
inadvertently undiagnosed.
In this exploratory analysis, we calculated that a ferritin
concentration threshold of 18·4 µg/l was predictive of micro-
cytosis in this cohort, albeit in a small group of children. We
observed that children with ferritin concentrations below
18·5 µg/l had significantly lower BSID-Ш cognitive scores at
2 years, raising the possibility that the current commonly used
WHO serum ferritin cut-off for Fe deficiency of 12 µg/l may
need re-evaluation. Based on our preliminary findings, 18·5 µg/l
may be considered a candidate threshold to identify those at
risk of adverse clinical outcomes or suboptimal development,
especially in high-resource settings, although, further research
with adequately powered validation studies are urgently
required to ascertain this. This is the first study to show that in a
healthy population where very low ferritin concentrations
(Fe deficiency) were uncommon, there was still a significant
adverse consequence of being in the lower end of the currently
defined normal range for ferritin concentrations. Longitudinal
studies have previously shown a persistent effect of Fe defi-
ciency at this stage(10), however, the long-term consequences of
this borderline low Fe status at this crucial phase of brain
development is yet to be elucidated.
In addition, ferritin concentrations at 2 years were positively
associated with BSID-Ш fine motor scores, in accordance with
previous studies(25,31). A number of animal studies have sug-
gested altered oligodendrocyte function due to Fe deficiency,
resulting in impaired myelination of neurons, affecting motor
function. Alterations in monoaminergic pathways, in particular
in dopamine metabolism have also been suggested to impact
motor development in early childhood(32).
The obligate reliance on global developmental assessments
at this age is a limitation in this area of research. Global
developmental assessments, including the BSID-Ш, have been
criticised for being too broad and not sensitive enough to
identify specific cognitive processes that are affected by nutri-
tional factors and do not correlate highly with later tests of
intelligence in school-age children(33,34). More specific mea-
sures of cognitive tasks, such as tests of memory and learning at
school-age may be of more importance to investigating the
more subtle effects of Fe deficiency and borderline low Fe
status(33).
A potential limitation of this study is that the analysis is cross-
sectional in design, although it is important to note that pro-
spectively collected maternal and early life data were used in
the analysis, thereby enabling deeper interpretation of the data
than would be possible with a cross-sectional survey. The
prospective design of the Cork BASELINE Birth Cohort Study,
with its multidisciplinary team, with both validated nutritional
and neurodevelopmental assessments performed by experts in
their field are strengths of this study. Our secondary analysis of
the nested subgroup within the cohort is limited by the small
sample size included, although the eighty-seven children
included were representative of the entire BASELINE cohort
(see Table 1) and this sample size is comparable to previous
observational studies in this field(24,25). However, adequately
powered studies are required to further investigate and expand
on our findings in this study with the aim to identify the best
measures of Fe status in young children. The exploration
of associations between Fe deficiency/Fe deficiency anaemia
and developmental outcomes were somewhat limited by the
small number of children with either condition, however this
is reflective of the high-resource population studied and gene-
ralisable to other similar low risk, healthy populations. Despite
the overall normal developmental profile of the group, we
still found a significant functional effect of microcytosis and
borderline normal/low Fe status.
Although the public health threat associated with Fe defi-
ciency has diminished in many low risk, high-resource settings,
the current study highlights that strategies aimed at preventing
Fe deficiency, but also low or suboptimal Fe status in young
children in such settings are still pertinent. Despite a low pre-
valence of Fe deficiency using current diagnostic criteria in this
apparently healthy cohort, microcytosis was still associated with
lower cognitive outcomes at 2 years. This study further
emphasises the need for re-consideration and evaluation of the
diagnostic criteria currently used to diagnose Fe deficiency and
Fe deficiency anaemia in infants and young children. Further
research is warranted to identify the most suitable biomarkers
and thresholds to ensure no children at risk of adverse clinical
or developmental consequences are inadvertently undiagnosed
and untreated.
Acknowledgements
The authors thank the participants and their families for their
continued support and both the SCOPE Ireland and Cork
BASELINE Birth Cohort Study research teams.
A grant from the National Children’s Research Centre to D. M. M.,
J. O’B. H., A. D. I., L. C. K. and M. E. K. is the primary funding
source for the Cork BASELINE Birth Cohort Study. Additional
Microcytosis and cognition at 2 years 365
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114517001945
Downloaded from https://www.cambridge.org/core. University College Cork, on 20 Sep 2017 at 11:01:29, subject to the Cambridge Core terms of use, available at
support came from grants from the UK Food Standards Agency to
J. O’B. H. and A. D. I. and from Danone Nutricia Early Life Nutrition
to M. E. K. and D. M. M. The SCOPE Ireland Study was funded by a
grant from the Health Research Board of Ireland (CSA 02/2007) to
L. C. K. The INFANT Research Centre is Science Foundation Ireland
funded (grant no. 12/RC/2272). No funding agencies had any role
in the design, analysis or writing of this article.
E. K. M. carried out data collection, database construction and
data analysis and drafted the first and subsequent drafts of the
manuscript. D. M. M. is the overall Principal Investigator (PI) of the
Cork BASELINE Birth Cohort Study and planned the study design,
aided in data analysis and manuscript preparation. M. E. K. is co-PI
and specialist nutrition lead of the Cork BASELINE Birth Cohort
Study and aided in study governance, design and manuscript
preparation. G. H. and C. A. carried out data collection and
database construction. L. C. K., J. O’B. H. and A. D. I. are co-PI
of the Cork BASELINE Birth Cohort Study and aided in study
governance and edited the final manuscript. L. C. K. is the PI of the
SCOPE Ireland pregnancy study. All authors reviewed and
approved the final submission.
The authors declare that there are no conflicts of interest.
Supplementary material
For supplementary material/s referred to in this article, please
visit https://doi.org/10.1017/S0007114517001945
References
1. Agostoni C, Decsi T, Fewtrell M, et al. (2008) Complementary
feeding: a commentary by the ESPGHAN Committee on
Nutrition. J Pediatr Gastroenterol Nutr 46, 99–110.
2. McCarthy EK, Ní Chaoimh C, Hourihane JO, et al. (2017) Iron
intakes and status of 2-year-old children in the Cork BASE-
LINE Birth Cohort Study. Matern Child Nutr 13, e12320.
3. Gunnarsson BS, Thorsdottir I & Palsson G (2004) Iron status in
2-year-old Icelandic children and associations with dietary
intake and growth. Eur J Clin Nutr 58, 901–906.
4. McLean E, Cogswell M, Egli I, et al. (2009) Worldwide pre-
valence of anaemia, WHO Vitamin and Mineral Nutrition
Information System, 1993–2005. Public Health Nutr 12,
444–454.
5. Eussen S, Alles M, Uijterschout L, et al. (2015) Iron intake and
status of children aged 6-36 months in Europe: a systematic
review. Ann Nutr Metab 66, 80–92.
6. Lozoff B & Georgieff MK (2006) Iron deficiency and brain
development. Semin Pediatr Neurol 13, 158–165.
7. Lozoff B (2007) Iron deficiency and child development. Food
Nutr Bull 28, 4 Suppl., S560–S571.
8. Lozoff B, Beard J, Connor J, et al. (2006) Long-lasting neural
and behavioral effects of iron deficiency in infancy. Nutr Rev
64, 5 Pt 2, S34–S43; discussion S72–S91.
9. Grantham-McGregor S & Ani C (2001) A review of studies
on the effect of iron deficiency on cognitive development
in children. J Nutr 131, 2S-2, 649S–666S; discussion
666S-668S.
10. Lozoff B, Smith JB, Kaciroti N, et al. (2013) Functional sig-
nificance of early-life iron deficiency: outcomes at 25 years.
J Pediatr 163, 1260–1266.
11. Kenny LC, Black MA, Poston L, et al. (2014) Early pregnancy
prediction of preeclampsia in nulliparous women, combining
clinical risk and biomarkers: the Screening for Pregnancy
Endpoints (SCOPE) international cohort study. Hypertension
64, 644–652.
12. O’Donovan SM, Murray DM, Hourihane JO, et al. (2015) Cohort
profile: The Cork BASELINE Birth Cohort Study: Babies after
SCOPE: Evaluating the Longitudinal Impact on Neurological
and Nutritional Endpoints. Int J Epidemiol 44, 764–775.
13. O’Neill SM, Hannon G, Khashan AS, et al. (2017) Thin-
for-gestational age infants are at increased risk of neuro-
developmental delay at 2 years. Arch Dis Child Fetal Neonatal
Ed 102, F197–F202.
14. McCowan LM, Thompson JM, Taylor RS, et al. (2013) Clinical
prediction in early pregnancy of infants small for gestational
age by customised birthweight centiles: findings from a
healthy nulliparous cohort. PLOS ONE 8, e70917.
15. Bayley N (2006) The Bayley Scales of Infant and Toddler
Development, 3rd ed. San Antonio, TX: The Psychological
Corporation.
16. Savchev S, Sanz-Cortes M, Cruz-Martinez R, et al. (2013)
Neurodevelopmental outcome of full-term small-for-gestational-
age infants with normal placental function. Ultrasound Obstet
Gynecol 42, 201–206.
17. Rao R & Georgieff MK (2007) Iron in fetal and neonatal
nutrition. Semin Fetal Neonatal Med 12, 54–63.
18. Thorisdottir AV, Thorsdottir I & Palsson GI (2011) Nutrition
and iron status of 1-year olds following a Revision in infant
dietary recommendations. Anemia 2011, 986303.
19. Vendt N, Grunberg H, Leedo S, et al. (2007) Prevalence and
causes of iron deficiency anemias in infants aged 9 to
12 months in Estonia. Medicina (Kaunas) 43, 947–952.
20. Lozoff B, Brittenham GM, Wolf AW, et al. (1987) Iron defi-
ciency anemia and iron therapy effects on infant develop-
mental test performance. Pediatrics 79, 981–995.
21. Brotanek JM, Gosz J, Weitzman M, et al. (2007) Iron deficiency
in early childhood in the United States: risk factors and racial/
ethnic disparities. Pediatrics 120, 568–575.
22. Freeman VE, Mulder J, van’t Hof MA, et al. (1998) A long-
itudinal study of iron status in children at 12, 24 and
36 months. Public Health Nutr 1, 93–100.
23. Shafir T, Angulo-Barroso R, Jing Y, et al. (2008) Iron defi-
ciency and infant motor development. Early Hum Dev 84,
479–485.
24. Gunnarsson BS, Thorsdottir I, Palsson G, et al. (2007) Iron
status at 1 and 6 years versus developmental scores at 6 years
in a well-nourished affluent population. Acta Paediatr 96,
391–395.
25. Thorisdottir AV, Gunnarsdottir I, Palsson GI, et al. (2013) Iron
status and developmental scores in 6-year-olds highlights
ongoing need to tackle iron deficiency in infants. Acta
Paediatr 102, 914–919.
26. Sherriff A, Emond A, Bell JC, et al. (2001) Should infants
be screened for anaemia? A prospective study investigating the
relation between haemoglobin at 8, 12, and 18 months and
development at 18 months. Arch Dis Child 84, 480–485.
27. Johnson SR, Winkleby MA, Boyce WT, et al. (1992) The
association between hemoglobin and behavior problems in a
sample of low-income Hispanic preschool children. J Dev
Behav Pediatr 13, 209–214.
28. Ruff HA, Markowitz ME, Bijur PE, et al. (1996) Relationships
among blood lead levels, iron deficiency, and cognitive
development in two-year-old children. Environ Health
Perspect 104, 180–185.
29. DeLoughery TG (2014) Microcytic anemia. N Engl J Med 371,
1324–1331.
30. Domellof M, Braegger C, Campoy C, et al. (2014) Iron
requirements of infants and toddlers. J Pediatr Gastroenterol
Nutr 58, 119–129.
366 E. K. McCarthy et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114517001945
Downloaded from https://www.cambridge.org/core. University College Cork, on 20 Sep 2017 at 11:01:29, subject to the Cambridge Core terms of use, available at
31. Shafir T, Angulo-Barroso R, Calatroni A, et al. (2006) Effects of
iron deficiency in infancy on patterns of motor development
over time. Hum Mov Sci 25, 821–838.
32. Doom JR & Georgieff MK (2014) Striking while the iron is hot:
understanding the biological and neurodevelopmental effects
of iron deficiency to optimize intervention in early childhood.
Curr Pediatr Rep 2, 291–298.
33. Wainwright PE & Colombo J (2006) Nutrition and the develop-
ment of cognitive functions: interpretation of behavioral studies
in animals and human infants. Am J Clin Nutr 84, 961–970.
34. Canals J, Hernandez-Martinez C, Esparo G, et al. (2011)
Neonatal Behavioral Assessment Scale as a predictor of cog-
nitive development and IQ in full-term infants: a 6-year
longitudinal study. Acta Paediatr 100, 1331–1337.
Microcytosis and cognition at 2 years 367
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114517001945
Downloaded from https://www.cambridge.org/core. University College Cork, on 20 Sep 2017 at 11:01:29, subject to the Cambridge Core terms of use, available at
